Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials

Saved in:
Bibliographic Details
Main Authors: Simon J. Gunter, MPhil, Martina L. Porter, MD, Alexa B. Kimball, MD, MPH
Format: Article
Language:English
Published: Wolters Kluwer 2024-10-01
Series:International Journal of Women's Dermatology
Online Access:http://journals.lww.com/10.1097/JW9.0000000000000171
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850180875656888320
author Simon J. Gunter, MPhil
Martina L. Porter, MD
Alexa B. Kimball, MD, MPH
author_facet Simon J. Gunter, MPhil
Martina L. Porter, MD
Alexa B. Kimball, MD, MPH
author_sort Simon J. Gunter, MPhil
collection DOAJ
format Article
id doaj-art-323645eec749492eb8ace3bcf75cb088
institution OA Journals
issn 2352-6475
language English
publishDate 2024-10-01
publisher Wolters Kluwer
record_format Article
series International Journal of Women's Dermatology
spelling doaj-art-323645eec749492eb8ace3bcf75cb0882025-08-20T02:18:01ZengWolters KluwerInternational Journal of Women's Dermatology2352-64752024-10-01103e17110.1097/JW9.0000000000000171202410000-00016Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trialsSimon J. Gunter, MPhil0Martina L. Porter, MD1Alexa B. Kimball, MD, MPH2a Harvard Medical School, Boston, Massachusettsb Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusettsb Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusettshttp://journals.lww.com/10.1097/JW9.0000000000000171
spellingShingle Simon J. Gunter, MPhil
Martina L. Porter, MD
Alexa B. Kimball, MD, MPH
Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials
International Journal of Women's Dermatology
title Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials
title_full Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials
title_fullStr Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials
title_full_unstemmed Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials
title_short Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials
title_sort placebo responders with moderate to severe hidradenitis suppurativa experience declines in inflammation as measured by c reactive protein a post hoc analysis of two double blinded randomized controlled trials
url http://journals.lww.com/10.1097/JW9.0000000000000171
work_keys_str_mv AT simonjguntermphil placeboresponderswithmoderatetoseverehidradenitissuppurativaexperiencedeclinesininflammationasmeasuredbycreactiveproteinaposthocanalysisoftwodoubleblindedrandomizedcontrolledtrials
AT martinalportermd placeboresponderswithmoderatetoseverehidradenitissuppurativaexperiencedeclinesininflammationasmeasuredbycreactiveproteinaposthocanalysisoftwodoubleblindedrandomizedcontrolledtrials
AT alexabkimballmdmph placeboresponderswithmoderatetoseverehidradenitissuppurativaexperiencedeclinesininflammationasmeasuredbycreactiveproteinaposthocanalysisoftwodoubleblindedrandomizedcontrolledtrials